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Background
Posttranscriptional mechanisms of gene regulation, par-
ticularly those affecting mRNA stability, are emerging as
critical effectors of gene expression changes. Although the
mechanisms determining mRNA turnover are poorly
understood, they are generally believed to involve RNA-
binding proteins recognizing specific RNA sequences. Best
characterized among the RNA sequences that influence
mRNA stability are AU-rich elements (AREs), usually
found in the 3'untraslated regions (UTR). The stability of
a particular mRNA is controlled by specific interactions
between structural elements of the mRNA and RNA-bind-
ing proteins. Of these proteins the best studied are AUF1
proteins that destabilize and ELAV-like proteins that stabi-
lizes different mRNAs.
The objective of the present investigation was to character-
ize the 3'UTR of the α2 mRNA and to study the molecular
mechanism accounting for the NMDA-dependent up-reg-
ulation of this mRNA in cerebellar granule cells in culture.
Results
As we have previously shown NMDA-treatment caused an
increase of the NO-sensitive guanylyl cyclase α2 mRNA.
This effect is transcriptional and translational independ-
ent but depends on the mRNA turnover. We have cloned
and sequenced the 3'flanking region of NO-sensitive gua-
nylyl cyclase α2 mRNA, using two oligonucleotide pairs
(one of them designed inside the coding region), which
amplify two overlapping products of 853 pb and 1167 pb.
The length of the complete fragment is 1873 pb (GenBank
accession number AY795577) and bears many AU-rich
motifs, which may be targets for the binding of different
proteins that may stabilize or destabilize the mRNA.
These fragments were employed to synthesize radiola-
beled RNA probes to perform RNA-protein binding assays
and protein-RNA complexes were observed in the assay
where the 853 pb fragment was incubated with nuclear
extracts obtained from cerebellar granule cells. The mRNA
encoding for α2 was immunoprecipitated by using specific
antibodies against AUF1, indicating that these proteins
bind to this particular mRNA "in vivo" and may affect its
stability. NMDA treatment effectively decreases the AUF1
protein levels in nuclear protein extracts and increases α2
mRNA, both effects were prevented by ODQ and KT5823,
inhibitors of guanylyl cyclase and cGMP-dependent pro-
tein kinase, which became activated by NMDA stimula-
tion. Thus, NMDA increases α2 mRNA stability in
cerebellar granule cells by decreasing the level of AUF1
proteins through a mechanism that implies cGMP synthe-
sis and activation of cGMP-dependent protein kinase.
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